arrow
I

Ian Pavord

University of Oxford
H指数:126
被引数:6.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)

一项跨国、研究者发起的、平行组、随机、双盲、安慰剂对照的3b期优效性试验方案,评估度普利尤单抗对高风险2型炎症性哮喘诱导临床缓解结局的影响(HOTHOT)

2026-04-110
OAAI
Budesonide–formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial

布地奈德–福莫特罗与特布他林缓解剂在正在使用维持性吸入性糖皮质激素的新西兰成人哮喘患者中的比较(INFORM ASTHMA):一项开放标签、平行组、随机对照、4期临床试验

2026-01-080
PRE
Transient Early Blood Eosinophil Increases Do Not Affect Dupilumab's Long-Term Efficacy in Patients with Moderate-to-Severe Asthma

中重度哮喘患者中,短暂的早期血液嗜酸性粒细胞增多不影响Dupilumab的长期疗效。

2025-11-140
PRE
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trial

一种用于成人哮喘管理的抗炎缓解算法方法:一项开放标签、单臂试验

2025-10-210
OAAI